Old Web
English
Sign In
Acemap
>
authorDetail
>
David Lloyd
David Lloyd
Amgen
Internal medicine
Antagonist
Chemistry
Endocrinology
Receptor
2
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
2021
Shu-Chen Lu
Michelle Chen
Larissa Atangan
Elizabeth A. Killion
Renee Komorowski
Yuan Cheng
Chawita Netirojjanakul
James R. Falsey
Marina Stolina
Denise Dwyer
Clarence Hale
Shanaka Stanislaus
Todd Hager
Veena A. Thomas
John M. Harrold
David Lloyd
Murielle M. Véniant
Show All
Source
Cite
Save
Citations (2)
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism.
2020
Nature Communications
Elizabeth A. Killion
Michelle Chen
James R. Falsey
Glenn Sivits
Todd Hager
Larissa Atangan
Joan Helmering
Jae Lee
Hongyan Li
Bin Wu
Yuan Cheng
Murielle M. Véniant
David Lloyd
Show All
Source
Cite
Save
Citations (18)
1